Director/PDMR Shareholding

RNS Number : 0895H

Arix Bioscience Plc

05 June 2017

 

05 June 2017 

ARIX BIOSCIENCE PLC

Director/PDMR Shareholding

LONDON, 05 June 2017: Arix Bioscience plc (LSE: ARIX) ("Arix Bioscience" or "the Company"), a global healthcare and life science company supporting medical innovation, announces that several key members of its leadership team have purchased shares in the Company.

Joe Anderson, Chief Executive Officer of Arix Bioscience, purchased 55,000 ordinary shares in the Company at a price of 206.10p per Ordinary Share.

James Rawlingson, Chief Financial Officer of Arix Bioscience, purchased 26,000 ordinary shares in the Company at a price of 206.10p per Ordinary Share. 

Jon Peacock, Chairman of Arix Bioscience, purchased 28,016 ordinary shares in the Company at a price of 206.10p per Ordinary Share.

PDMR DEALING NOTIFICATION
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Joseph Anderson
2	Reason for the notification
a)	Position / status	Chief Executive Officer
b)	Initial notification / Amendment	Initial Notification
3	Details of issuer
a)	Name	Arix Bioscience plc
b)	LEI	213800OVT3AHQCXNIX43
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of Arix Bioscience plc
	Identification code	GB00BD045071
b)	Nature of the transaction	Purchase of Ordinary Shares
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		206.10 pence	55,000
d)	Aggregated information	Aggregated price	Aggregated volume
		N/A (single transaction)	N/A (single transaction)
e)	Date of the transaction	02 June 2017
f)	Place of the transaction	London Stock Exchange (XLON)

PDMR DEALING NOTIFICATION
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	James Hedley Rawlingson
2	Reason for the notification
a)	Position / status	Chief Financial Officer
b)	Initial notification / Amendment	Initial Notification
3	Details of issuer
a)	Name	Arix Bioscience plc
b)	LEI	213800OVT3AHQCXNIX43
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of Arix Bioscience plc
	Identification code	GB00BD045071
b)	Nature of the transaction	Purchase of Ordinary Shares
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		206.10 pence	26,000
d)	Aggregated information	Aggregated price	Aggregated volume
		N/A (single transaction)	N/A (single transaction)
e)	Date of the transaction	02 June 2017
f)	Place of the transaction	London Stock Exchange (XLON)

PDMR DEALING NOTIFICATION
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Jonathan Peacock
2	Reason for the notification
a)	Position / status	Chairman
b)	Initial notification / Amendment	Initial Notification
3	Details of issuer
a)	Name	Arix Bioscience plc
b)	LEI	213800OVT3AHQCXNIX43
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of Arix Bioscience plc
	Identification code	GB00BD045071
b)	Nature of the transaction	Purchase of Ordinary Shares
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		206.10 pence	28,016
d)	Aggregated information	Aggregated price	Aggregated volume
		N/A (single transaction)	N/A (single transaction)
e)	Date of the transaction	02 June 2017
f)	Place of the transaction	London Stock Exchange (XLON)

For further information:

James Rawlingson                           Chief Financial Officer                [phone]

 - Ends -

 

END

 

 

DSHFZLLBDQFEBBB